Request Consultation
Request Consultation

Clinical Insights

The more you know about an abnormal or difficult-to-interpret imaging finding, the better you can manage it. Videssa Breast evaluates breast abnormalities at a biochemical level thus, serving as an ideal diagnostic complement to imaging, which evaluates anatomical features.  When considering additional imaging and/or biopsy, Videssa Breast can help answer challenging clinical questions and identify patients who may or may not need immediate follow-up.


To Biopsy or Not to Biopsy?

  • With an NPV greater than 98 percent, a low protein signature test result on Videssa Breast indicates that there is less than two percent probability of breast cancer, independent of imaging, which can help reduce the number of biopsies performed among:
    • BI-RADS 3 patients insisting on biopsy, Videssa can help guide a patient to forego biopsy and reduce the anxiety of “watchful waiting”
    • Women assessed in the BI-RADS 3/BI-RADS 4A “gray zone,” where next steps may be unclear, Videssa increases confidence in negative results to identify patients who may not warrant immediate follow-up
    • Women with abnormal mammograms who are at an elevated risk, Videssa can provide increased confidence in “watchful waiting”

Is Advanced Imaging Needed?

  • The Videssa Breast test result can help determine the need for additional imaging among:
    • Women with dense breasts, where imaging may be difficult to interpret or make a cancer easy to miss/overlook – a high protein signature test result can help identify patients who warrant additional imaging and/or more frequent follow-up
    • BI-RADS 3 patients considering additional imaging, Videssa Breast helps determine the timing of imaging—immediate versus six-months